Envisioneering Medical Technologies

Envisioneering Medical Technologies was a medical device company specializing in advanced ultrasound imaging and biopsy systems for the diagnosis of prostate cancer. The company's flagship product, the TargetScan system, utilized 3D ultrasound technology to provide precise, stationary-probe imaging for targeted prostate biopsies. By improving the accuracy of tissue sampling, Envisioneering aimed to enhance the detection and management of urological malignancies. The company's technology allowed for a more systematic and reproducible approach to prostate mapping compared to traditional freehand methods. Envisioneering was acquired by BK Medical in 2009 to strengthen its urology imaging portfolio. Today, its innovations continue to influence the field of urological ultrasound through its integration into larger medical imaging platforms.